Zobrazeno 1 - 10
of 12
pro vyhledávání: '"B. J. F. van den Bemt"'
Autor:
C. C. M. Stuijt, B. J. F. van den Bemt, V. E. Boerlage, M. J. A. Janssen, K. Taxis, F. Karapinar-Çarkit
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Although medication reconciliation (MedRec) is mandated and effective in decreasing preventable medication errors during transition of care, hospitals implement MedRec differently. Objective Quantitatively compare the number and t
Externí odkaz:
https://doaj.org/article/3339703068984d299f323e7d74e763b3
Autor:
M. J. H. Voshaar, B. J. F. van den Bemt, M. A. F. J. van de Laar, A. M. van Dulmen, J. E. Vriezekolk
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Disease-modifying anti-rheumatic drugs (DMARDs) are the cornerstone of rheumatoid arthritis (RA) treatment. However, the full benefits of DMARDs are often not realized because many patients are sub-optimally adherent to their medi
Externí odkaz:
https://doaj.org/article/425338a6b63a49329721324af10718c6
Autor:
M. J. H. Voshaar, J. E. Vriezekolk, A. M. van Dulmen, B. J. F. van den Bemt, M. A. F. J. van de Laar
Publikováno v:
BMC Musculoskeletal Disorders, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Introduction Facilitators and barriers of adherence to disease-modifying anti-rheumatic drugs (DMARDs) have been identified by patients with inflammatory arthritis earlier. However, the relative importance from the patients’ perspective of
Externí odkaz:
https://doaj.org/article/c1a4c1cec7584f968ec7c4fd40b1e81e
Publikováno v:
BMC Musculoskeletal Disorders, Vol 22, Iss 1, Pp 1-10 (2021)
BMC Musculoskeletal Disorders, 22
BMC Musculoskeletal Disorders, 22(1):21. BioMed Central Ltd
BMC musculoskeletal disorders, 22(1):21. BioMed Central
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders, 22, 1
BMC Musculoskeletal Disorders, 22
BMC Musculoskeletal Disorders, 22(1):21. BioMed Central Ltd
BMC musculoskeletal disorders, 22(1):21. BioMed Central
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders, 22, 1
Introduction Facilitators and barriers of adherence to disease-modifying anti-rheumatic drugs (DMARDs) have been identified by patients with inflammatory arthritis earlier. However, the relative importance from the patients’ perspective of these fa
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 164
Annually, in the Netherlands, at least 100 million euro is wasted on unused medication. This waste not only has considerable economic implications, but is also associated with an unnecessary burden on the environment and suboptimal care due to nonadh
Autor:
S, Daliri, C L, Bekker, B M, Buurman, W J M, Scholte Op Reimer, B J F, van den Bemt, F, Karapinar-Çarkit
Publikováno v:
International journal of clinical pharmacy. 43(3)
Background Medication management is jeopardized during a patient's transition from hospital to home. Insight is required from both hospital and primary healthcare providers on how care should be organised to achieve continuity of medication managemen
Autor:
B J F, van den Bemt
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 164
Prescription of medication is one of the most common medical interventions. Just half of patients use a prescribed preventative medication in accordance with the doctor's instructions; this leads to a smaller effect from the medication, side effects
Publikováno v:
Diagnose en therapie 2011 ISBN: 9789031382859
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdb5d1359296f09fa9f444603f275005
https://doi.org/10.1007/978-90-313-8286-6_19
https://doi.org/10.1007/978-90-313-8286-6_19
Publikováno v:
Diagnose en therapie 2009 ISBN: 9789031352821
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60181e9e1d6ca5d202017ddb68ef00bd
https://doi.org/10.1007/978-90-313-6613-2_17
https://doi.org/10.1007/978-90-313-6613-2_17
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 151(19)
There has been much discussion regarding the cardiovascular and gastrointestinal safety of traditional and COX-2 selective NSAIDs. The national and international guidelines differ in their recommendations. Selective COX-2 inhibitors seem to have a di